CAS 1469924-27-3 appears in our catalog under these names: 3-(4'-(Dimethylamino)-[1,1'-biphenyl]-3-yl)-1,1-dimethylurea, 99%, 3-[4'-(Dimethylamino)[1,1'-biphenyl]-3-yl]-1,1-dimethylurea, >98.0%(HPLC)(T), Atglistatin, Atglistatin/ 99.81% (existing batch purity), Atglistatin, 99.44%. Offered by: BLDpharm, TCI, Chemat Brand, TargetMol, GLPBio. Available pack sizes: 1mg, 5mg, 10mg, 50mg, 100mg, 250mg, on request, 2mg.
Atglistatin is a biphenyl that is 1,1'-biphenyl substituted by (dimethylcarbamoyl)amino and dimethylamino groups at positions 3 and 4', respectively. It is a potent inhibitor of adipose triglyceride lipase activity (IC50 = 700nM). It has a role as an EC 3.1.1.3 (triacylglycerol lipase) inhibitor and a cardioprotective agent. It is a member of biphenyls, an aromatic amine, a member of ureas and a tertiary amino compound.
Source: ChEBI
| Molecular formula | C17H21N3O |
|---|---|
| Molecular weight | 283.37 g/mol |
| IUPAC name | 3-[3-[4-(dimethylamino)phenyl]phenyl]-1,1-dimethylurea |
| InChIKey | AWOPBSAJHCUSAS-UHFFFAOYSA-N |
| SMILES | CN(C)C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)N(C)C |
Computed by PubChem (NCBI)